Oakworth Capital’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.69K Hold
970
﹤0.01% 502
2025
Q1
$7.28K Hold
970
﹤0.01% 547
2024
Q4
$7.29K Sell
970
-50
-5% -$376 ﹤0.01% 523
2024
Q3
$7.75K Hold
1,020
﹤0.01% 525
2024
Q2
$6.3K Hold
1,020
﹤0.01% 540
2024
Q1
$5.18K Hold
1,020
﹤0.01% 530
2023
Q4
$6.11K Sell
1,020
-100
-9% -$599 ﹤0.01% 524
2023
Q3
$7.93K Hold
1,120
﹤0.01% 468
2023
Q2
$7.89K Hold
1,120
﹤0.01% 499
2023
Q1
$9.34K Hold
1,120
﹤0.01% 442
2022
Q4
$12.9K Buy
1,120
+100
+10% +$1.15K ﹤0.01% 393
2022
Q3
$13K Hold
1,020
﹤0.01% 416
2022
Q2
$11K Hold
1,020
﹤0.01% 427
2022
Q1
$17K Hold
1,020
﹤0.01% 398
2021
Q4
$14K Hold
1,020
﹤0.01% 453
2021
Q3
$15K Hold
1,020
﹤0.01% 434
2021
Q2
$16K Hold
1,020
﹤0.01% 427
2021
Q1
$10K Buy
1,020
+970
+1,940% +$9.51K ﹤0.01% 454
2020
Q4
$0 Hold
50
﹤0.01% 573
2020
Q3
$0 Hold
50
﹤0.01% 572
2020
Q2
$0 Hold
50
﹤0.01% 558
2020
Q1
$0 Sell
50
-50
-50% ﹤0.01% 521
2019
Q4
$0 Hold
100
﹤0.01% 550
2019
Q3
$0 Hold
100
﹤0.01% 574
2019
Q2
$0 Hold
100
﹤0.01% 617
2019
Q1
$0 Hold
100
﹤0.01% 575
2018
Q4
$1K Hold
100
﹤0.01% 554
2018
Q3
$1K Hold
100
﹤0.01% 574
2018
Q2
$1K Hold
100
﹤0.01% 605
2018
Q1
$0 Hold
100
﹤0.01% 608
2017
Q4
$1K Hold
100
﹤0.01% 587
2017
Q3
$1K Hold
100
﹤0.01% 599
2017
Q2
$1K Hold
100
﹤0.01% 592
2017
Q1
$1K Sell
100
-50
-33% -$500 ﹤0.01% 594
2016
Q4
$1K Hold
150
﹤0.01% 600
2016
Q3
$1K Hold
150
﹤0.01% 573
2016
Q2
$1K Hold
150
﹤0.01% 554
2016
Q1
$0 Hold
150
﹤0.01% 561
2015
Q4
$2K Hold
150
﹤0.01% 467
2015
Q3
$2K Hold
150
﹤0.01% 389
2015
Q2
$2K Hold
150
﹤0.01% 397
2015
Q1
$1K Hold
150
﹤0.01% 436
2014
Q4
$2K Hold
150
﹤0.01% 402
2014
Q3
$2K Hold
150
﹤0.01% 375
2014
Q2
$2K Hold
150
﹤0.01% 379
2014
Q1
$2K Hold
150
﹤0.01% 382
2013
Q4
$1K Buy
+150
New +$1K ﹤0.01% 398